• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma" [Canc. Lett. 476 (2020) 48-56].

作者信息

Leung Hoi Wing, Lau Eunice Yuen Ting, Leung Carmen Oi Ning, Lei Martina Mang Leng, Mok Etienne Ho Kit, Ma Victor Wan San, Cho William Chi Shing, Ng Irene Oi Lin, Yun Jing Ping, Cai Shao Hang, Yu Hua Jian, Ma Stephanie, Lee Terence Kin Wah

机构信息

Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong.

Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong.

出版信息

Cancer Lett. 2021 Feb 28;499:2. doi: 10.1016/j.canlet.2020.06.007. Epub 2020 Jun 17.

DOI:10.1016/j.canlet.2020.06.007
PMID:32563702
Abstract
摘要

相似文献

1
Corrigendum to "NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma" [Canc. Lett. 476 (2020) 48-56].《NRF2/SHH信号级联促进肝细胞癌肿瘤起始细胞谱系及耐药性》[《癌症快报》476卷（2020年）第48 - 56页]的勘误
Cancer Lett. 2021 Feb 28;499:2. doi: 10.1016/j.canlet.2020.06.007. Epub 2020 Jun 17.
2
NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma.NRF2/SHH 信号级联促进肝癌肿瘤起始细胞谱系和耐药性。
Cancer Lett. 2020 Apr 28;476:48-56. doi: 10.1016/j.canlet.2020.02.008. Epub 2020 Feb 13.
3
Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].《“MicroRNA-21通过AKT/ERK途径抑制PTEN和hSulf-1表达并促进肝细胞癌进展”的勘误》[《癌症快报》337 (2013) 226 - 236]
Cancer Lett. 2020 Mar 31;473:198-199. doi: 10.1016/j.canlet.2019.12.034. Epub 2020 Jan 8.
4
Corrigendum to "Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells" [Canc. Lett. 469 (2020) 498-509].《昼夜节律钟基因NPAS2促进肝癌细胞葡萄糖代谢重编程》的勘误[《癌症通讯》469 (2020) 498 - 509]
Cancer Lett. 2021 Nov 28;521:322-323. doi: 10.1016/j.canlet.2021.09.006. Epub 2021 Sep 11.
5
Corrigendum to "Long non-coding RNA Unigene 56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells" [Canc. Lett. 382 (2016) 166-175].《“长链非编码RNA Unigene 56159通过作为肝细胞癌细胞中miR-140-5p的ceRNA促进上皮-间质转化”的勘误》[《癌症快报》382 (2016) 166 - 175]
Cancer Lett. 2020 Mar 1;472:181-182. doi: 10.1016/j.canlet.2019.12.021. Epub 2019 Dec 24.
6
Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].《AGBL2通过IRGM调节的自噬和增强的极光激酶A活性促进肝癌细胞生长》[《癌症通讯》414(2018)71 - 80]的勘误
Cancer Lett. 2022 Jul 28;539:215700. doi: 10.1016/j.canlet.2022.215700. Epub 2022 May 4.
7
Corrigendum to "LncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells" [Canc. Lett. 429 (2018) 89-99].《“LncRNA n335586/miR-924/CKMT1A轴促进肝癌细胞的迁移和侵袭”的勘误》[《癌症快报》429 (2018) 89 - 99]
Cancer Lett. 2020 Dec 1;494:84-87. doi: 10.1016/j.canlet.2020.07.018. Epub 2020 Sep 7.
8
Corrigendum to "cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells" [Canc. Lett. 403 (2017) 260-270].《“cPLA2α在肝癌细胞上皮-间质转化过程中激活PI3K/AKT并抑制Smad2/3”的勘误》[《癌症快报》403卷（2017年）260 - 270页]
Cancer Lett. 2021 Feb 1;498:240-241. doi: 10.1016/j.canlet.2020.11.009. Epub 2020 Nov 19.
9
Corrigendum to "miR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma" [Canc. Lett. 335 (2013) 351-360].《“miR-371-5p下调前体mRNA加工因子4同源物B（PRPF4B）并促进人肝细胞癌的G1/S期转换”的勘误》[《癌症快报》335卷（2013年）第351 - 360页]
Cancer Lett. 2021 May 1;505:87-90. doi: 10.1016/j.canlet.2021.02.015. Epub 2021 Mar 5.
10
Corrigendum to "Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma" [Canc. Lett. 503 (2021) 43-53].
Cancer Lett. 2022 Jul 1;537:215688. doi: 10.1016/j.canlet.2022.215688. Epub 2022 Apr 19.